no worries, i do it all the time not putting my glasses on and booking appointments at wrong times so totally understand. i am not a bit optimistic i am very optimistic. also 3million ebita for the year currently i believe. i also believe there are cost savings in the new gear which is far more efficient in addition to the increased output and that they will be going for more lucrative markets with higher margins. so yes 20 million is probably top of the wozza but if our experience with the company to date is anything to go by, they pull rabbits out of hats but the market has not recognised it of late. in any case i am confident that this is a low point and am buying as many as finances allow. good luck to all who buy now now or are holders and totally understand if people hold back until the ship steadies. it all depends on the type of investor you are. i am the kinda of the bigger the risk the bigger the reward although i this case i dont feel it is much risk just big rewards
- Forums
- ASX - By Stock
- Ann: Executive and Board Transition to Support Suvo's Expansion
no worries, i do it all the time not putting my glasses on and...
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.6¢ |
Change
0.002(4.55%) |
Mkt cap ! $42.51M |
Open | High | Low | Value | Volume |
4.3¢ | 4.9¢ | 4.0¢ | $80.39K | 1.903M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 237166 | 4.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 180306 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 307456 | 0.046 |
1 | 12000 | 0.043 |
1 | 746741 | 0.042 |
5 | 1541793 | 0.040 |
1 | 1000000 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 82290 | 1 |
0.050 | 49931 | 2 |
0.053 | 100000 | 1 |
0.054 | 80000 | 1 |
0.056 | 100000 | 1 |
Last trade - 14.51pm 15/07/2024 (20 minute delay) ? |
Featured News
SUV (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online